🔗 Share this article Social Media Influencers Driving Parallel Trade for Unlicensed Weight-Loss Medication An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings. Investigational Drug Gaining Traction Online Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes. Active Trade on Messaging Platforms Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for purchases. Learning About Retatrutide This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic. Healthcare Experts Express Concerns Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could result in users administering products of uncertain source. Several experts said the demand for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro. Regulatory Position and Implementation Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012. Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or imprisonment. Platform Reaction and Material Elimination Based on the social media company, the platform has taken down violative content and prohibited associated keywords and query recommendations. The organization said it was dedicated to keeping the service secure and investing in enhancing enforcement strategies. Online Trading Activities Research also found communities with up to nine thousand participants selling retatrutide using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or administering at home. After minutes of entering one community, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience. Product Information and Costs Within these communities, messages show black plastic parcels with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.” Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how long a pen should last, vendors give conflicting answers varying between a several days to “depends on your body”. Platform Moderation and Security Actions A representative for the messaging service said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”. Medical Expert Warnings “People are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained. Her team has previously seen patients injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These substances could be contaminated or improperly measured.” Manufacturer Statement A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially significant health risks”.